Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
67 studies found for:    "Encephalitis, Japanese"
Show Display Options
Rank Status Study
1 Completed Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
Condition: Encephalitis, Japanese B
Intervention: Biological: Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine
2 Completed
Has Results
Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children
Condition: Encephalitis, Japanese B
Intervention: Biological: JEVAC
3 Completed
Has Results
Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
Condition: Encephalitis, Japanese B
Intervention: Biological: Live attenuated SA 14-14-2 vaccine
4 Active, not recruiting Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose
Condition: Encephalitis, Japanese
Intervention: Biological: SA-14-14-2 live, attenuated JE vaccine
5 Completed Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis
Condition: Japanese Encephalitis
Intervention: Drug: Intravenous immunoglobulin [ImmunoRel™ (batch 20081217)]
6 Completed Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis
Condition: Japanese Encephalitis
Interventions: Biological: Mouse brain derived japanese encephalitis vaccine (MB-JEV);   Biological: Primary and booster immunizations with MB-JEV;   Biological: C) primary immunizations with Ixiaro;   Biological: S) Ixiaro booster to MBJEV primed
7 Completed
Has Results
Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects
Condition: Japanese Encephalitis
Intervention: Biological: Live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®)
8 Completed A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2
Conditions: Japanese Encephalitis;   Japanese Encephalitis Vaccine
Intervention: Biological: Live attenuated Japanese encephalitis vaccine SA14-14-2
9 Unknown  Treatment of Japanese Encephalitis
Condition: Japanese Encephalitis
Intervention: Drug: Ribavirin
10 Completed
Has Results
Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic Country
Condition: Japanese Encephalitis
Intervention: Biological: IXIARO
11 Enrolling by invitation Seroepidemiology of Japanese Encephalitis Virus Infection in Hualien, Taiwan
Condition: Japanese Encephalitis
Intervention:
12 Completed
Has Results
Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
13 Completed
Has Results
Immunogenicity Study of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Interventions: Biological: IC51;   Biological: JE-VAX
14 Completed
Has Results
Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
15 Completed Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis live attenuated SA 14-14-2 vaccine
16 Completed
Has Results
Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: Japanese Encephalitis purified inactivated vaccine
17 Unknown  Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis chimeric vaccine (JECV)
18 Completed Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis live attenuated SA 14-14-2 vaccine
19 Completed
Has Results
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX
Condition: Japanese Encephalitis
Interventions: Biological: ChimeriVax™-JE;   Biological: JE-VAX®
20 Completed
Has Results
Safety and Tolerability of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Interventions: Biological: Japanese Encephalitis purified inactivated vaccine (IC51);   Biological: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.